ABBOTT LABORATORIES Public Float
ABBOTT LABORATORIES (ABT) had Public Float of $232.17 billion as of 2025-06-30, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-20
- 2025-06-30: Entity Public Float $232.17B.
- 2024-06-28: Entity Public Float $177.07B.
- 2023-06-30: Entity Public Float $185.17B.
- 2022-06-30: Entity Public Float $186.11B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $232.17B 10-K · filed 2026-02-20 |
| 2024-06-28 | $177.07B 10-K · filed 2025-02-21 |
| 2023-06-30 | $185.17B 10-K · filed 2024-02-16 |
| 2022-06-30 | $186.11B 10-K · filed 2023-02-17 |
| 2021-06-30 | $200.63B 10-K · filed 2022-02-18 |
| 2020-06-30 | $157.96B 10-K · filed 2021-02-19 |
| 2019-06-28 | $144.96B 10-K · filed 2020-02-21 |
| 2018-06-30 | $104.31B 10-K · filed 2019-02-22 |
| 2017-06-30 | $82.27B 10-K · filed 2018-02-16 |
| 2016-06-30 | $56.38B 10-K · filed 2017-02-17 |
| 2015-06-30 | $71.34B 10-K · filed 2016-02-19 |
| 2014-06-30 | $59.98B 10-K · filed 2015-02-27 |
| 2013-06-30 | $52.88B 10-K · filed 2014-02-21 |
| 2012-06-30 | $98.00B 10-K · filed 2013-02-15 |
| 2011-06-30 | $79.09B 10-K · filed 2012-02-21 |
| 2010-06-30 | $69.68B 10-K · filed 2011-02-18 |
| 2009-06-30 | $70.20B 10-K · filed 2010-02-19 |
| 2008-06-30 | $78.77B 10-Q · filed 2009-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |